GRDN — Guardian Pharmacy Services, Inc. stock price, charts and financials

QT79Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. (NYSE: GRDN) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
42.37
-1.46-3.33%
OverviewShort InterestFilings
GRDNQT79Guardian Pharmacy Services, Inc.·NYSE
42.37-3.33%
News
Down 3.3% — Guardian Pharmacy Services Q2 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
ACHC+0.70%$31.75NHC+0.32%$216.22BKD-4.85%$13.53ADUS+0.11%$119.81MD-3.51%$26.13OPCH+3.03%$24.51AVAH-0.64%$9.43SEM-0.12%$16.51
Snapshot
Index-P/E41.74EPS (ttm)1.05Insider Own-Shs Outstand63.32MPerf Week10.88%
Market Cap2.78BForward P/E32.27EPS next Y1.36Insider Trans-17.98%Shs Float51.12MPerf Month6.75%
Enterprise Value2.69BPEG0.14EPS next Q-Inst Own-Short Float5.46%Perf Quarter20.84%
Income65.78MP/S1.90EPS this Y51.81%Inst Trans-Short Ratio6.70Perf Half Y33.34%
Sales1.46BP/B10.77EPS next Y7.80%ROA14.86%Short Interest2.79MPerf YTD45.66%
Book/sh-P/C26.46EPS next 5Y9.35%ROE30.37%52W High45.45 -6.78%Perf Year109.31%
Cash/sh-P/FCF34.34EPS past 3/5Y10.38% 18.77%ROIC21.45%52W Low18.66 127.10%Perf 3Y-
Dividend Est.-EV/EBITDA23.62Sales past 3/5Y16.82% 14.51%Gross Margin21.63%Volatility4.84% 4.23%Perf 5Y-
Dividend TTM-EV/Sales1.84EPS Y/Y TTM146.89%Oper. Margin6.27%ATR (14)2.09Perf 10Y-
Dividend Ex-Date-Quick Ratio1.33Sales Y/Y TTM18.57%Profit Margin4.50%RSI (14)61.96Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.65EPS Q/Q38.10%SMA208.04%Beta0.76Target Price45.33
Payout0.00%Debt/Eq0.03Sales Q/Q2.43%SMA507.44%Rel Volume2.60Prev Close43.83
Employees3,600LT Debt/Eq0.14EarningsNov 17SMA20025.86%Avg Volume402.68KPrice42.37
IPO DateSep 26, 2024Option/ShortYes / YesEPS/Sales Surpr.20.83% 2.03%Net Debt/EBITDA-0.72Volume1,045,061Change-3.33%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-07-26ReiteratedOppenheimerOutperform$43 → $49
Jun-17-26ReiteratedTruist SecuritiesBuy$38 → $47
Mar-12-26ReiteratedRaymond James$28 → $40
Mar-12-26ReiteratedTruist SecuritiesBuy$34 → $38
Jan-14-26ReiteratedStephens & Co.Overweight$36
Nov-14-25ReiteratedTruist SecuritiesBuy$30 → $34
Oct-10-25InitiatedOppenheimerOutperform$30
Sep-26-25ReiteratedTruist SecuritiesBuy$30
May-14-25ReiteratedRaymond James$25 → $28
Latest News
Aug-08-26
Aug-08-2606:03AM
Guardian Pharmacy Services Q2 Earnings Call Highlightsmarketbeat.com
Aug-07-26
Aug-07-2607:24AM
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-06-26
Aug-06-2604:05PM
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidancebusinesswire.com
04:14AM
First Trust Advisors LP Purchases Shares of 93,677 Guardian Pharmacy Services, Inc. $GRDNdefenseworld.net
03:14AM
Arrowstreet Capital Limited Partnership Buys 16,866 Shares of Guardian Pharmacy Services, Inc. $GRDNdefenseworld.net
Jul-22-26
Jul-22-2603:48AM
Bessemer Group Inc. Purchases Shares of 78,656 Guardian Pharmacy Services, Inc. $GRDNdefenseworld.net
Jul-15-26
Jul-15-2604:30PM
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Callbusinesswire.com
Jul-13-26
Jul-13-2606:33AM
Guardian Pharmacy Services: Growth Is Durable, But Valuation Is FullSeekingAlpha
Jul-01-26
Jul-01-2604:32PM
Guardian Pharmacy Services Acquires Wellness Concepts; Terms Not DisclosedBenzinga
04:30PM
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Conceptsbusinesswire.com
Jun-29-26
Jun-29-2609:06AM
Bet on Winning DuPont Analysis & Pick 5 Top Stockszacks.com
06:56AM
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?zacks.com
Jun-22-26
Jun-22-2604:31PM
Guardian Pharmacy Services Appoints CFO David Morris As COO, Effective July 1Benzinga
Jun-17-26
Jun-17-2610:48AM
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47Benzinga
07:59AM
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47Benzinga
Company

Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,4641,4491,228——————
Cost of Goods Sold Incl. D&A1,1471,167984——————
Gross Profit317282244——————
Selling, General and Administrative Excl. Other225193307——————
Research and Development
000——————
Other Operating Expense
000——————
Operating Income9389-63——————
Interest Expense013——————
Unusual Expense
—————————
Non-Operating Income (Expense)5-150——————
Net Income Before Taxes9673-66——————
Income Taxes30245——————
Consolidated Net Income6649-87——————
Net Income From Continuing Operations6749-71——————
Net Income6649-87——————
EPS (Recurring)1.050.79-1.77——————
EPS (Basic, Before Extraordinaries)1.050.79-1.77——————
EPS (Diluted)1.030.78-1.77——————
EBITDA11496-43——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio41.1438.58———————
Price To Sales Ratio1.821.291.02——————
Gross Margin21.6519.4619.87——————
Operating Margin6.356.14-5.13——————
Net Margin4.513.38-7.08——————
Shares Outstanding636262——————
Market Capitalization2,6691,8661,256——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$47.45$39.60$31.75$23.90$16.05● Close Price0.00M104.81M209.63M314.44M419.26MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Pharmacy Investors, LLCother: Member of 10% owner groupMar 28 '26Option Exercise0.001,413,93902,449,867Mar 31
BINDLEY WILLIAM Edirector, 10 percent owner:Mar 28 '26Option Exercise0.006,100,175010,569,491Mar 31
Forbes KendallSee RemarksMar 28 '26Option Exercise0.00608,57001,061,826Mar 31
Morris David KSee RemarksMar 28 '26Option Exercise0.00641,8690896,341Mar 31
Cardinal Equity Fund, L.P.other: Member of 10% owner groupMar 28 '26Option Exercise0.00471,0570816,180Mar 31
Bindley Capital Partners I, LLC10% OwnerMar 28 '26Option Exercise0.006,100,175010,569,491Mar 31
Salentine Thomas J Jrdirector, 10 percent owner:Mar 28 '26Option Exercise0.006,100,175010,569,491Mar 31
Ackerman JohnDirectorMar 28 '26Option Exercise0.001,884,99602,449,867Mar 31
Burke FredSee RemarksMar 28 '26Option Exercise0.001,298,82602,139,239Mar 31
Pharmacy Investors, LLCother: Member of 10% owner groupMar 20 '26Sale29.68827,63624,566,3061,035,928Mar 24
Morris David KSee RemarksMar 20 '26Sale29.68187,8555,576,006254,472Mar 24
Burke FredSee RemarksMar 20 '26Sale29.68671,43219,929,780840,413Mar 24
Forbes KendallSee RemarksMar 20 '26Sale29.68346,67210,290,092453,256Mar 24
Cardinal Equity Fund, L.P.other: Member of 10% owner groupMar 20 '26Sale29.68275,7288,184,296345,123Mar 24
Salentine Thomas J Jrdirector, 10 percent owner:Mar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.